Quarterly assessment on the feasibility of insurance drug reimbursement eyed

The Health Insurance Review Agency (HIRA) plans to conduct its quarterly assessment on the feasibility of insurance drug reimbursement involved in frequently occurring diseases based on the recently finalized program from the Central Evaluation Committee for Diagnosis Screening.
Under the HIRA's plan, the additional item subject to feasibility assessment of drug reimbursement this year include...